However, while not reaching statistical significance, there was an observed trend towards increased miR-133a expression at 320 μM.
← all excerpts
The role of miR-133a in silibinin-mediated inhibition of the PI3K/AKT/mTOR pathway in MCF-7 breast carcinoma cells.
1
—
—